China Regenerative Medicine International Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was HKD 51.92 million compared to HKD 40.98 million a year ago. Net income was HKD 1.12 million compared to net loss of HKD 7.66 million a year ago.

Basic earnings per share from continuing operations was HKD 0.00039. Diluted earnings per share from continuing operations was HKD 0.00039. Basic earnings per share was HKD 0.00039 compared to basic loss per share of HKD 0.00269 a year ago.